7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Acrivon Therapeutics, Inc.
(NASDAQ:ACRV) 

ACRV stock logo

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to specific medicine by utilizing its proteomics-based patient responder identification platform, Acrivon ...

Founded: 2018
Full Time Employees: 35
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Acrivon Therapeutics . Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0241.26482.52723.79965.051,206.311,447.571,688.84
Acrivon Therapeutics . Op Cashflow Per Share ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.91-1.64-1.36-1.09-0.82-0.55-0.270
Acrivon Therapeutics . Free Cashflow Per Share ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.97-1.69-1.4-1.12-0.84-0.56-0.280
Acrivon Therapeutics . Cash Per Share ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.653.294.946.588.239.8711.52
Acrivon Therapeutics . (GAAP) P/E ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -10.07-8.63-7.19-5.75-4.31-2.88-1.440
Acrivon Therapeutics . P/B ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -6.87-5.63-4.4-3.17-1.93-0.70.541.77
No extra charts and metrics for this ticker.